Cristália Produtos Químicos Farmacêuticos Ltda.

This is a very early safety study testing a new treatment called CRIS100 for people who have just suffered a severe spinal cord injury in their upper back. Five participants will receive a single injection of CRIS100 directly into the injury site within 72 hours of their accident…

This is an early safety study testing a potential new treatment for overdoses in healthy volunteers. Researchers will give 12 healthy adults different doses of the treatment to see how their bodies react and process it. The main goal is to check for side effects and understand ho…